Pre-release: this release has not been published. Identifiers are permanent; descriptions may still change.
21 U.S.C. 360bb Designation of drugs for rare diseases or conditions
21 U.S.C. 360bb Designation of drugs for rare diseases or conditions, “Designation of drugs for rare diseases or conditions”, is a U.S. Code section of Part B—Drugs for Rare Diseases or Conditions; in force.
https://ontology.bommaritollc.com/id/01a0f06c-cd1e-70fc-bda3-7fe5eb2d38cf
Elsewhere
Facts
| adms:identifier | |
| eli:cites | |
| prov:wasDerivedFrom | |
| schema:isPartOf | |
| schema:legislationIdentifier | 21 U.S.C. 360bb |
| schema:legislationJurisdiction | |
| schema:legislationLegalForce | |
| schema:legislationType | |
| schema:name | Designation of drugs for rare diseases or conditionsen |
| schema:url | |
| skos:prefLabel | 21 U.S.C. 360bb Designation of drugs for rare diseases or conditionsen |
Related
Cited by (15)eli:cites
- 21 U.S.C. 355a Pediatric studies of drugs
- 21 U.S.C. 355c Research into pediatric uses for drugs and biological products
- 21 U.S.C. 360cc Protection for drugs for rare diseases or conditions
- 21 U.S.C. 360dd Open protocols for investigations of drugs for rare diseases or conditions
- 21 U.S.C. 360ee Grants and contracts for development of drugs for rare diseases and conditions
- 21 U.S.C. 360ff Priority review to encourage treatments for rare pediatric diseases
- 21 U.S.C. 360ff-1 Targeted drugs for rare diseases
- 21 U.S.C. 379h Authority to assess and use drug fees
- 26 CFR 1.28-1 Credit for clinical testing expenses for certain drugs for rare diseases or conditions.
- 42 U.S.C. 1320f-1 Selection of negotiation-eligible drugs as selected drugs
- 42 U.S.C. 1395l Payment of benefits
- 42 U.S.C. 236 Orphan Products Board
- 42 U.S.C. 256b Limitation on prices of drugs purchased by covered entities
- 42 U.S.C. 262 Regulation of biological products
- 42 U.S.C. 287 National Center for Advancing Translational Sciences